Background {#Sec1}
==========

The switch from a mainly petroleum to a sustainable bioeconomy has become omnipresent over the last years. Consequently, research is focusing on the development of biotechnological production processes, resulting in biochemicals able to compensate for petrochemicals. One group of these chemicals is organic acids, such as succinate, malate, or itaconate.

Especially the C5-dicarboxylic acid, itaconate, has gained great interest, due to a broad range of possible applications in different industries and technologies, such as in carbon fibers, rubber, anti-scaling polymers in water treatment, cement additives, surface active agents, plastics, and dye intermediates \[[@CR1]--[@CR3]\]. Additionally, it can be converted into different value-added molecules, due to its multiple functional groups \[[@CR1]\] or be used for self-polymerization to poly-itaconate, which has the potential to replace a broad range of different polymers \[[@CR4]--[@CR6]\]. In 2004, itaconate was announced one of the top twelve building block chemicals, to be produced from renewable biomass, by the U.S. Department of Energy \[[@CR1]\]. Even though the contemporary market for itaconate is rather small with about 41 kt a^−1^ in 2013, corresponding to a market value of approximately US\$ 74.5 million, it is predicted to reach US\$ 570 million by 2020 \[[@CR7]\]. This huge increase in the expected market volume is based on the possibility to substitute existing chemicals, if an improved production process can be developed that would lower the price for itaconate.

Chemical synthesis of itaconate was first reported in 1836 \[[@CR8]--[@CR10]\] and in 1931, *Aspergillus* *itaconicus* was the first organism to be found to produce itaconate \[[@CR11]\]. In contrast to many other chemicals, contemporary itaconate production is completely achieved by biotechnological processes \[[@CR2]\]. These processes mainly rely on *A.* *terreus* strains. The first *A.* *terreus* strain producing itaconate was discovered in 1939 \[[@CR12]\] and since then, the use of this organism has been investigated and improved intensively for the production of itaconic acid \[[@CR13]--[@CR15]\]. Over the years, many different organisms have been found to produce itaconate, including several species of *Pseudozyma* \[[@CR16], [@CR17]\], *Ustilago* \[[@CR18]--[@CR21]\], and different *Candida* \[[@CR22]\] and *Rhodotorula* \[[@CR23]\] species.

Many of these production strains are a member of the family of Ustilaginaceae, which is a promising fungal family for biotechnological applications \[[@CR24]--[@CR26]\]. Recently, the itaconate production pathway in *U.* *maydis* has been clarified, allowing for targeted metabolic engineering of itaconate production in this host \[[@CR27], [@CR28]\].

The family of Ustilaginaceae is generally known for combining natural production of different industrially relevant products, such as organic acids, polyols, and lipids from a broad range of substrates, with favorable characteristics for biotechnological processes, such as a yeast-like morphology, insensitivity to medium impurities and tolerance to high product titers \[[@CR4], [@CR19]--[@CR21], [@CR24], [@CR25], [@CR29]--[@CR35]\]. Especially, the broad substrate range attracted interest in this group of organisms. As plant pathogens, Ustilaginaceae are able to degrade a broad range of polymers from biomass, such as cellulose, hemicellulose, or xylan \[[@CR36]--[@CR39]\]. Recently, malate production from biodiesel-derived glycerol has been demonstrated with *Ustilago* *trichophora* TZ1 \[[@CR40]--[@CR42]\]. The use of glycerol as substrate for microbial conversion has been discussed frequently over the last years. In a follow-up study of the landmark 2004 DOE report \[[@CR1]\], glycerol is still considered as one of the 10 most promising building blocks to be produced \[[@CR43]\]. However, worldwide increasing biodiesel production has resulted in a huge side stream of (crude) glycerol, which makes up 10% (w/v) of the total production. With 123 million tons of biodiesel per year predicted for 2016 \[[@CR44]\], 19 million tons of crude glycerol will flood the market, further lowering the price, while simultaneously decreasing the profit margin for the biodiesel production process itself. Consequently, valorization of this huge waste-stream has been discussed intensively, resulting in several microbial production processes for different products starting from glycerol \[[@CR45], [@CR46]\].

Here we present *U.* *vetiveriae* TZ1 as promising production organism for organic acids from glycerol, reaching high total acid titers with itaconate and malate as the main products. Further, we demonstrate that by single overexpression of two different genes, the acid production profile can be drastically influenced in favor of itaconate.

Results and discussion {#Sec2}
======================

Submersed cultivation reveals *U.* *vetiveriae* as a promising itaconate producer {#Sec3}
---------------------------------------------------------------------------------

Recently, we reported on an *U.* *trichophora* strain, which was found in a broad screening of Ustilaginaceae, to naturally produce malate from glycerol \[[@CR40]\]. The primary screening in this study was performed on agar plates with a pH indicator, only resulting in a qualitative indication of growth and semi-quantitative indication concerning total acid production. Due to the generally high malate production of many Ustilaginaceae \[[@CR21]\], this method is less suited for finding producers of other organic acids such as itaconate. Consequently, we performed a complete screening of 126 Ustilaginaceae cultivated in 24-deep well plate liquid cultures \[[@CR47]\] containing mTM with 50 g L^−1^ glycerol, 0.8 g L^−1^ NH~4~Cl, and 100 g L^−1^ CaCO~3~. After 355 h, the culture supernatants were initially evaluated for glycerol uptake (Fig. [1](#Fig1){ref-type="fig"}a) and strains with the highest glycerol uptake rate were selected for further analysis.Fig. 1Screening for the production of organic acids from glycerol. **a** Rank-ordered glycerol concentration after 355 h of cultivation in 24-deep well plates containing MTM with 50 g L^−1^ glycerol, 0.8 g L^−1^ NH~4~Cl, and 100 g L^−1^ CaCO~3~ for 126 different Ustilaginaceae. The glycerol concentrations and strain numbers are indicated in Table [3](#Tab3){ref-type="table"}. Strains with high-glycerol consumption (indicated by the *red box*) were re-screened for acid production. **b** Rank-ordered itaconate concentration (*open circles*), malate concentration (*closed squares*), and succinate concentration (*open triangles*) after 383 h of cultivation in 24-deep well plates containing MTM with 100 g L^−1^ glycerol, 0.8 g L^−1^ NH~4~Cl, and 100 g L^−1^ CaCO~3~ for 24 selected Ustilaginaceae. Strains with good production (indicated by *arrows*) were evaluated in detail. **c** Malate concentration and **d** itaconate concentration for different Ustilaginaceae cultivated in shake flasks containing MTM with 200 g L^−1^ glycerol, 0.8 g L^−1^ NH~4~Cl, and 100 g L^−1^ CaCO~3~. *Error bars* indicate deviation from the mean (*n* = 2)

As reported previously for Ustilaginaceae \[[@CR21], [@CR40]\], a broad phenotypic distribution was observed. Some strains consumed all carbon, while others did not grow at all on glycerol (Fig. [1](#Fig1){ref-type="fig"}a). Although organic acid production was observed with a broad diversity, titers were generally low due to the low concentration of glycerol used. Hence, we chose the 24 strains with fastest glycerol uptake (indicated by the red box in Fig. [1](#Fig1){ref-type="fig"}a), to investigate in a second 24-deep well plate screening with a higher initial glycerol concentration of 100 g L^−1^ (Fig. [1](#Fig1){ref-type="fig"}b). From this screening, the six strains with best itaconate and malate production properties (Fig. [1](#Fig1){ref-type="fig"}b) and highest glycerol uptake (indicated by arrows in Fig. [1](#Fig1){ref-type="fig"}b) were chosen and cultivated in shake flasks containing 200 g L^−1^ glycerol. Only three of these strains, *U.* *vetiveriae*, *U.* *xerochloae*, and *Sporisorium iseilematis*-*ciliati* were able to produce itaconate, reaching a titer of 4.4 ± 0.8, 20.1 ± 4.6, and 8.5 ± 1.8 g L^−1^, respectively, while all strains produced malate with titers between 10.5 ± 0.7 and 63.1 ± 0.3 g L^−1^. Even though production rates and titers for itaconate are lower than for *A.* *terreus* \[[@CR48]\] and *P.* *antarctica* \[[@CR16]\] on glucose, they are rather high for wild-type strains, given the applied conditions, leaving space for improvement.

Adaptive laboratory evolution improves growth and acid production on glycerol {#Sec4}
-----------------------------------------------------------------------------

Adaptive laboratory evolution (ALE) is known to be suitable for the improvement of specific microbial characteristics by adaptation to the chosen environmental conditions and selection of beneficial mutations \[[@CR49]--[@CR51]\]. Recently, we were able to improve malate production, growth rate, and glycerol uptake in *U.* *trichophora* by ALE \[[@CR40]\]. Here we used the same re-inoculation scheme in shake flasks applying faster growth rate and consequently higher glycerol uptake rates as selection pressure for all six strains from the last screening in duplicates. While growth rate could not be increased except for *U.* *vetiveriae*, glycerol uptake was improved for all strains. Additionally, malate production was improved for all strains (Table [1](#Tab1){ref-type="table"}). Figure [2](#Fig2){ref-type="fig"}a shows the results for *U.* *vetiveriae* RK075. Although the maximum glycerol uptake rate was not improved for this strain, the initial glycerol consumption was significantly improved by ALE, indicating an increased growth rate before the onset of nitrogen limitation.Table 1Outcome of the ALEGrowth (h^−1^)Glycerol rate (g L^−1^ h^−1^)Itaconate titer (g L^−1^)Itaconate rate (g L^−1^ h^−1^)Malate titer (g L^−1^)Malate rate (g L^−1^ h^−1^)*U. vetiveriae* RK 0750.05 ± 0.00 (0.07 ± 0.00)0.30 ± 0.01 (0.31 ± 0.03)4.4 ± 0.8 (10.4 ± 2.1)0.01 ± 0.00 (0.03 ± 0.01)11.5 ± 0.5 (26.6 ± 4.7)0.03 ± 0.00 (0.07 ± 0.01)*U. xerochloae* UMa7020.05 ± 0.00 (0.05 ± 0.00)0.35 ± 0.0 (0.63 ± 0.00)20.1 ± 4.6 (0.0 ± 0.0)0.05 ± 0.01 (0.00 ± 0.00)10.5 ± 0.7 (81.2 ± 8.4)0.03 ± 0.00 (0.21 ± 0.02)*Macalpinomyces mackinlayi* BRIP 52549 a0.05 ± 0.00 (0.05 ± 0.00)0.38 ± 0.00 (0.64 ± 0.01)0.0 ± 0.0 (0.0 ± 0.0)0.00 ± 0.00 (0.00 ± 0.00)63.1 ± 0.3 (35.5 ± 0.3)0.17 ± 0.00 (0.09 ± 0.00)*M. ordensis* BRIP 26904 a0.04 ± 0.00 (0.04 ± 0.00)0.30 ± 0.01 (0.62 ± 0.01)0.0 ± 0.0 (0.0 ± 0.0)0.00 ± 0.00 (0.00 ± 0.00)30.6 ± 2.3 (79.6 ± 2.5)0.08 ± 0.01 (0.21 ± 0.01)*U. xerochloae* BRIP 60876 a0.04 ± 0.00 (0.04 ± 0.00)0.26 ± 0.01 (0.65 ± 0.00)0.0 ± 0.0 (0.0 ± 0.0)0.00 ± 0.00 (0.00 ± 0.00)26.8 ± 1.4 (37.3 ± 2.1)0.07 ± 0.00 (0.10 ± 0.01)*S. iseilematis*-*ciliati* BRIP 60887 a0.04 ± 0.00 (0.04 ± 0.00)0.38 ± 0.00 (0.50 ± 0.00)8.5 ± 1.8 (0.0 ± 0.0)0.02 ± 0.01 (0.00 ± 0.00)16.4 ± 2.8 (1.4 ± 0.4)0.04 ± 0.01 (0.00 ± 0.00)Comparison of growth rate, glycerol uptake rate and organic acid (itaconate, malate) titer and production rate before and after ALE. Values in brackets correlate to values after ALE. ±values indicate deviation from the mean (*n* = 2) Fig. 2Adaptive laboratory evolution of *U.* *vetiveriae* RK075. **a** ALE of *U.* *vetiveriae* on glycerol as sole carbon source. A single representative culture is shown. **b** Comparison of growth (*squares*, *solid lines*) and glycerol consumption (*circles*, *dashed lines*) and **c** itaconate (*diamonds*, *solid lines*) and malate (*triangles*, *dashed lines*) production for *U.* *vetiveriae* RK075 (*black*, *closed symbols*) and *U.* *vetiveriae* TZ1 (*red*, *open symbols*) on glycerol.*Error bars* indicate deviation from the mean (*n* = 2)

Since the malate titers stayed below the titer reached with the previously published *U.* *trichophora* TZ1 \[[@CR40], [@CR41], [@CR52]\] or *A.* *oryzae* \[[@CR53], [@CR54]\], we focused on the strains producing itaconic acid. However, none of the initially identified itaconate producers produced itaconate after the 25th re-inoculation. Investigation of the cultures after 21 rounds of re-inoculation revealed that only *U.* *vetiveriae* was still able to produce itaconic acid (Table [1](#Tab1){ref-type="table"}). Apparently, itaconate production is detrimental to the fitness of these strains under the applied ALE conditions, leading to lower or completely abolished production after prolonged ALE. The putative natural functions of itaconate include the competition with other microbes by a drop in pH and the liberation of micronutrients through chelating properties \[[@CR27]\], both not required under these laboratory conditions. However, itaconate production is not expected to occur as long as a nitrogen source is present. Possibly, an altered ALE strategy with elevated ammonium levels and re-inoculation at lower cell densities may avoid the loss of itaconate production during ALE. Another possibility would be the investigation of itaconic acid production for all evolved strains after each re-inoculation. Even though *U.* *vetiveriae* stopped itaconate production after the 25th re-inoculation during ALE, it was still able to produce considerable amounts of itaconate after 21 re-inoculations. The best single colony (*U.* *vetiveriae* TZ1) isolated from the 21st re-inoculation, which corresponds to about 105 generations, produced 10.4 ± 2.1 g L^−1^ itaconate within 384 h at a production rate of 0.03 ± 0.01 g L^−1^ h^−1^ (Fig. [2](#Fig2){ref-type="fig"}c). In comparison, the reference strain (before ALE) produced 4.4 ± 0.8 g L^−1^ at a rate of 0.01 ± 0.00 g L^−1^ h^−1^ (Fig. [2](#Fig2){ref-type="fig"}c). Since the supplied amount of nitrogen was the same in both cultures and the final optical density was in the same range, this increase can actually be attributed to a higher specific production rate (g~malate~ g~biomass~^−1^ h^−1^). Additionally, malate production in this strain was improved, reaching 26.6 ± 4.7 g L^−1^ at a rate of 0.07 ± 0.01 g L^−1^ h^−1^, whereas the reference produced 11.5 ± 0.5 g L^−1^ at a rate of 0.03 ± 0.00 g L^−1^ h^−1^. Although the itaconic acid titer of *U.* *xerochloae* in the initial screening was higher, we focused on the evolved *U.* *vetiveriae* strain for further investigation because morphological and physiological characteristics of *U. xerochloae* (e.g., filamentous growth) interfered with downstream analytics and reproducibility.

Since the clustered genes, responsible for itaconate production in *U.* *maydis* have been discovered recently \[[@CR27]\], and the genome for *U.* *vetiveriae* was sequenced \[[@CR55]\], we determined the presence of the itaconate cluster in this novel strain. Overall, proteins encoded in the *U.* *vetiveriae* cluster have 70--90% sequence similarity to their counterparts from *U.* *maydis* except for Ria1, which shows only 44% sequence identity (Fig. [3](#Fig3){ref-type="fig"}). This indicates that itaconate production likely proceeds via the same pathway \[[@CR27]\]. This similarity is further supported, by the presence of 2-hydroxyparaconate in *U.* *vetiveriae* cultures, which is assumed to be a degradation product of itaconate \[[@CR28]\], and the existence of the respective genes in the cluster.Fig. 3Itaconate clusters. Comparison of the itaconate cluster of *U.* *maydis* MB215 to the itaconate cluster of *U.* *vetiveriae* RK075 on protein level. Genes present in the itaconate cluster encode a putative Cytochrome P450 monooxygenase (*cyp3*), a putative ring-cleaving dioxygenase, a trans-aconitate decarboxylase (*tad1*), a Major Facilitator Superfamily transporter (*ita1*), an aconitate-Δ-isomerase (*adi1*), a putative mitochondrial tricarboxylate transporter (*mtt1*), and a putative transcriptional regulator (*ria1*). *Numbers* indicate NCBI BLAST identity in percentage

Medium optimization elevates itaconate production with *U.* *vetiveriae* TZ1 {#Sec5}
----------------------------------------------------------------------------

Even though production values both for malic acid, as well as itaconic acid were improved by ALE, the reached titers and production rates are still low compared to published values \[[@CR16], [@CR28], [@CR40], [@CR48], [@CR53]\]. To further improve production properties, medium optimization was performed. The influence of differing concentrations of medium components on microbial production processes for organic acids, biomass, and proteins has been shown consistently in the literature for different organisms, such as *Aspergilli* \[[@CR14], [@CR56]--[@CR58]\], Ustilaginaceae \[[@CR21], [@CR59]\], and *Corynebacterium* *glutamicum* \[[@CR60]\]. Additionally, the used concentration of nitrogen and the used nitrogen source itself (e.g., ammonium chloride, yeast extract, and peptone) drastically changed acid production in different organisms \[[@CR16], [@CR29], [@CR40], [@CR59]\]. Consequently, we tested changing concentrations of NH~4~Cl (0.8, 1.6, 3.2 g L^−1^), FeSO~4~ (3, 13, 53, 103 mg L^−1^), KH~2~PO~4~ (0.125, 0.25, 0.5, 1 g L^−1^), and MgSO~4~ (0.1, 0.2, 0.5 g L^−1^), while keeping the concentration of all other components in the MTM unaltered. Additionally, we used peptone (2 g L^−1^) or yeast extract (2.4, 4.8 g L^−1^) instead of ammonium chloride. These two complex medium components contain 12.47 and 8.54% nitrogen, respectively, as determined by elemental analysis. Thus, the nitrogen (N) content of the different nitrogen sources was determined to correspond to 19 mM (0.8 g L^−1^ NH~4~Cl), 37 mM (1.6 g L^−1^ NH~4~Cl), 75 mM (3.2 g L^−1^ NH~4~Cl), 18 mM (2.0 g L^−1^ peptone), 15 mM (2.4 g L^−1^ yeast extract), and 0.29 mM (4.8 g L^−1^ yeast extract).

Altered concentrations of FeSO~4~, KH~2~PO~4~, and MgSO~4~ did not change organic acid production with *U.* *vetiveriae* TZ1 (data not shown). Changing the nitrogen concentration and source itself, however, drastically improved growth, glycerol uptake, and organic acid production (Fig. [4](#Fig4){ref-type="fig"}).Fig. 4Medium optimization for *U.* *vetiveriae* TZ1. **a** OD~600~, **b** glycerol concentration, **c** itaconate concentration, and **d** malate concentration for *U.* *vetiveriae* TZ1 cultivated in 24-deep well plates containing MTM with 200 g L^−1^ glycerol, 100 g L^−1^ CaCO~3~ and different concentrations of NH~4~Cl, yeast extract (YE) or peptone. *Error bars* indicate deviation from the mean (*n* = 3)

As expected, a higher ammonium chloride concentration increased final OD~600~ and volumetric glycerol uptake rates. However, growth of *U.* *vetiveriae* was delayed, possibly due to higher stress levels resulting from high ammonium concentrations. This effect was previously observed using *U.* *trichophora* \[[@CR41]\]. As expected, volumetric acid production rates improved with increasing NH~4~Cl concentrations, due to higher biomass concentrations. However, with 3.2 g L^−1^ NH~4~Cl, the final titer was reduced in comparison to 1.6 g L^−1^ NH~4~Cl. Even though in comparison to 0.8 g L^−1^ NH~4~Cl, the amount of supplied nitrogen was slightly lower for 2 g L^−1^ peptone, and 2.4 g L^−1^ yeast extract, itaconate production was greatly improved with the latter two N sources. In contrast to ammonium chloride, the use of these complex nitrogen sources resulted in an earlier onset of growth, consequently also resulting in an earlier production phase. Likely, yeast extract and peptone are less toxic to the cells in the initial growth stage, and their uptake and incorporation into biomass are energetically favorable. The uptake of di-, tri-, and possibly even oligopeptides is more efficient, since energy is spent for the uptake of one molecule, while several amino acids can be scavenged. The resulting surplus of energy leads to an overall improved biomass yield \[[@CR61]\]. The highest itaconate titer of 34.7 ± 2.5 g L^−1^ was reached with 4.8 g L^−1^ yeast extract produced at a rate of 0.09 ± 0.01 g L^−1^ h^−1^. Simultaneously 46.2 ± 1.4 g L^−1^ malate was produced.

Product inhibition by itaconate is likely stronger than product inhibition by malate {#Sec6}
------------------------------------------------------------------------------------

For malate production with *U.* *trichophora* TZ1, a drastic increase in production rate could be achieved in controlled bioreactors \[[@CR41]\]. Hence, we also investigated itaconate production with *U.* *vetiveriae* TZ1 in fed-batch cultivations with 200 g L^−1^ initial glycerol. Using 3.2 g L^−1^ NH~4~Cl or 5 g L^−1^ yeast extract resulted in a production rate of 0.06 ± 0.00 g L^−1^ h^−1^, which is similar to the values observed in 24-deep well plates (Fig. [5](#Fig5){ref-type="fig"}b; Table [2](#Tab2){ref-type="table"}). Surprisingly, the titer (about 24 g L^−1^), was not increased for either culture, even though additional glycerol was fed throughout the fermentation. The experiments were repeated and the parameters were changed but in all bioreactor cultivations a titer of about 24 g L^−1^ itaconate could not be exceeded (data not shown). In CaCO~3~-buffered shake flasks, in contrast, higher concentrations were reached. This hints at product inhibition by itaconic acid concentrations above 24 g L^−1^.Fig. 5Controlled batch cultivations of *U.* *vetiveriae* TZ1 with different nitrogen concentrations. **a** OD~600~, **b** itaconate concentration, and **c** malate concentration, for cultures in MTM containing 200 g L^−1^ initial glycerol at 30 °C and pH 6.5 with DO kept at 80%. *Colors* indicate different initial nitrogen concentrations: 5 g L^−1^ yeast extract (*circles*, *red*), 1.6 g L^−1^ NH~4~Cl (*diamonds*, *light green*), 3.2 g L^−1^ NH~4~Cl (*squares*, *dark green*), and 6.4 g L^−1^ NH~4~Cl with doubled concentration of all medium components except glycerol (*triangles*, *black*). *Error bars* indicate deviation from the mean (*n* = 2) Table 2Characteristics of the bioconversionTiter (g L^−1^) (itaconate)Rate (g L^−1^ h^−1^) (itaconate)Yield (g~ita~ g~gly~^−1^) (itaconate)Titer (g L^−1^) (malate)5 g L^−1^ YE23.5 ± 1.40.06 ± 0.000.08 ± 0.0237.2 ± 2.01.6 g L^−1^ NH~4~Cl18.0 ± 0.70.05 ± 0.000.06 ± 0.0118.3 ± 1.33.2 g L^−1^ NH~4~Cl24.1 ± 0.20.06 ± 0.000.07 ± 0.0060.0 ± 10.46.4 g L^−1^ NH~4~Cl13.3 ± 0.50.05 ± 0.000.07 ± 0.0026.5 ± 0.44.8 g L^−1^ YE (shake flask)34.7 ± 2.50.09 ± 0.010.18 ± 0.0146.2 ± 1.4Comparison of titer, rate, and yield for itaconate and titer of the main by-product malate for different bioreactor cultivations and the best shake flask cultivation. ±values indicate deviation from the mean (*n* = 3 for shake flask, *n* = 2 for bioreactors)

We described this effect previously in the context of malic acid formation with *U.* *trichophora* TZ1, where in CaCO~3~-buffered shake flasks and bioreactors, a concentration of about 200 g L^−1^ was reached, while in NaOH-buffered bioreactors a concentration of about 140 g L^−1^ was limiting \[[@CR41]\]. The concentration of dissolved malic acid in the culture broth of CaCO~3~-buffered cultures was determined to be about 15 g L^−1^ throughout the cultivation, consequently lowering the osmotic stress for the cells \[[@CR40]\]. For itaconic acid, the concentration of dissolved acid in CaCO~3~-buffered water was determined to be about 11 g L^−1^ (Tim Massmann, personal communication) with precipitation of the residual itaconate as calcium itaconate, strengthening the hypothesis of product inhibition by higher dissolved itaconic acid concentrations in NaOH-titrated bioreactors. Since also for *U.* *vetiveriae* TZ1 malic acid concentrations of up to 60.0 ± 10.4 g L^−1^ were reached in bioreactors, product inhibition by itaconic acid seems to be stronger than by malic acid. Also, a synergistic effect of inhibition by malate and itaconate cannot be excluded. Consequently, for a feasible production process, in situ product removal would be needed and the amount of malate as a by-product must be reduced. The possibility of in situ product removal for itaconate production has been demonstrated, making continuous production processes with Ustilaginaceae a promising option \[[@CR34], [@CR62]\]. Another possibility would be further ALE on higher itaconic acid concentrations in the medium, to obtain a strain which is less sensitive towards this product, provided that a loss of production can be avoided.

Apart from the observed product inhibition, the nitrogen source had a strong influence on fermentation performance. As expected, a lowered NH~4~Cl concentration (1.6 g L^−1^ NH~4~Cl) resulted in a lowered volumetric itaconate and malate production rate (Fig. [5](#Fig5){ref-type="fig"}b; Table [2](#Tab2){ref-type="table"}), due to lower biomass formation (Fig. [5](#Fig5){ref-type="fig"}a). In contrast to results observed with *U.* *trichophora* TZ1 for malate production \[[@CR41]\], 6.4 g L^−1^ NH~4~Cl combined with a doubled concentration for all other medium components resulted in neither rate nor titer improvement, rather reducing the growth rate and final OD~600~-values (Fig. [5](#Fig5){ref-type="fig"}a). In all, it seems that *U.* *vetiveriae* TZ1 is less tolerant to higher concentrations of ammonium or other medium salts than *U.* *trichophora* TZ1. In order to achieve higher cell densities and thus production rates, strains with improved tolerance towards higher salt concentrations can likely be isolated by additional ALE selection under ammonium stress, or an ammonium-fed process could be applied.

The use of 5 g L^−1^ yeast extract resulted in the same production values as the use of 3.2 g L^−1^ NH~4~Cl (Table [2](#Tab2){ref-type="table"}), even though only 40% of the nitrogen is supplied (30 mM vs. 75 mM). Additionally, cultures grown in bioreactors with yeast extract showed an earlier onset of the growth and production phase, just as in shake flasks. However, the use of yeast extract in the production of bulk fermentation products is often a cost-prohibitive factor. Likely even with a higher concentration of NH~4~Cl or another nitrogen source, such as (NH~4~)SO~4~ of (NH~4~)NO~3~, the overall process would be more cost-effective. Cultivations with *U.* *maydis* using these nitrogen sources resulted in high acid titers compared to acidic nitrogen sources, such as NH~4~H~2~PO~4~ or NH~4~Cl, even though the main effect was argued to result from higher final pH values in barely buffered shake flask cultivations \[[@CR20]\]. Yet, these observations would also correspond to first results with *U.* *vetiveriae* TZ1 cultivated in bioreactors at pH 4.5 and 5.5 (data not shown). At pH 4.5, no itaconate and malate production could be observed, while at pH 5.5 itaconate was still produced at a low titer of 8.0 ± 0.8 g L^−1^. Notably, in this cultivation, no malate was produced, suggesting a strategy for single product formation.

Even though itaconate production could not be improved in bioreactors, malate production was elevated. With 3.2 g L^−1^ NH~4~Cl, the malate titer increased to 60.0 ± 10.4 g L^−1^ produced within 403 h (Fig. [5](#Fig5){ref-type="fig"}c; Table [2](#Tab2){ref-type="table"}). Just as for itaconate, malate production was reduced both with higher and lower NH~4~Cl concentrations. With yeast extract, malic acid production was improved compared to the production with 1.6 g L^−1^ NH~4~Cl, even though the contained nitrogen content is about 20% lower. These high values for malic acid underline the higher tolerance of Ustilaginaceae against malic acid compared to itaconic acid, even though, a specific production process for itaconic acid without by-product formation would be preferred.

Metabolic engineering shifts organic acid production towards itaconate {#Sec7}
----------------------------------------------------------------------

Product specificity and hence product yield on substrate are important factors in microbial production processes. The simultaneous production of several organic acids in one strain results in a lowered titer for the desired product. Additionally, product recovery is more complex with similar compounds in the medium \[[@CR63]\]. Thus, a strain producing one organic acid with high specificity is desirable. The possibility to improve microbial organic acid production processes by overexpression of the specific underlying production pathways has been shown consistently for different organisms and products \[[@CR52], [@CR53], [@CR64]--[@CR67]\]. In previous studies on itaconate production from glucose with *U.* *maydis* MB215, overexpression of the mitochondrial transporter *mtt1* and the regulator *ria1* of the itaconate gene cluster led to improved itaconate and reduced malic acid production \[[@CR27], [@CR68]\]. Additionally, the formation of the assumed degradation product of itaconate, 2-hydroxyparaconate, was influenced in the same way as itaconate production itself \[[@CR28], [@CR68]\]. Thus, in order to investigate whether it is possible to shift the product spectrum of *U. vetiveriae* towards itaconate in a similar manner, we created mutants of *U.* *vetiveriae* RK075 overexpressing either *mtt1* or *ria1* from *U.* *maydis* MB215. For overexpression, we used a plasmid (pUMa43 Otef--gfp--nos--cbx) for *U.* *maydis*, which confers resistance to carboxin by site-specific integration into the *ip* ^R^-locus. Previously we showed that this plasmid can also confer resistance to carboxin in other Ustilaginaceae, such as *U.* *trichophora*, even though site specificity is not given. Additionally, all contained genetic elements, such as promoter and terminator, were functional in other Ustilaginaceae \[[@CR52]\].

Cultivation of the *U.* *vetiveriae* overexpression mutants in 24-deep well plates containing MTM with 0.8 g L^−1^ NH~4~Cl, 200 g L^−1^ glycerol, and 100 g L^−1^ CaCO~3~ resulted in a 1.5-fold and twofold increased itaconate production after 384 h for *U.* *vetiveriae* overexpressing *mtt1* and *ria1*, respectively (Fig. [6](#Fig6){ref-type="fig"}a). Simultaneously, malate production was reduced to 75% for *mtt1* and 59% for *ria1* (Fig. [6](#Fig6){ref-type="fig"}b). Also the values for 2-hydroxyparaconate production were in line with the previously published results. This opens up further steps for improvement by deletion of the respective genes, since 2-hydroxyparaconate is an assumed degradation product of itaconate \[[@CR28], [@CR68]\].Fig. 6Overexpression of *ria1* and *mtt1* in *U.* *vetiveriae* RK075. **a** Itaconate and **b** malate concentration after 384 h cultivation for *U.* *vetiveriae* RK075 overexpressing *mtt1* (*red*), *ria1* (*blue*), and *U. vetiveriae* RK075 (*black*) cultivated in 24-deep well plates containing MTM with 200 g L^−1^ glycerol, 100 g L^−1^ CaCO~3~, and 0.8 g L^−1^ NH~4~Cl. *Error bars* indicate deviation from the mean (*n* = 3)

This shift of organic acid production in favor of itaconate upon overexpression of either *ria1* or *mtt1* is comparable to the one in *U.* *maydis* MB215 both on glucose \[[@CR68]\] and glycerol (data not shown). From these results, it was assumed that the mitochondrial transporter Mtt1 is the bottleneck of itaconate production in *U.* *maydis*, which can be overcome directly by overexpression of *mtt1*, or indirectly by overexpression of the regulator *ria1* \[[@CR68]\]. This bottleneck seems also to be present in *U.* *vetiveriae* and can be overcome by single overexpression of *mtt1* or *ria1* from *U.* *maydis* MB215. These data indicate that not only the above-mentioned 70--90% sequence similarity for the proteins in the itaconate cluster of *U.* *vetiveriae* and *U.* *maydis* are sufficient for efficient heterologous expression but also the regulator of the itaconate cluster from *U.* *maydis* (*ria1*), in spite of a low similarity of 44%, is functional in *U.* *vetiveriae* and even other *Ustilago* strains, such as *U.* *xerochloae* (data not shown). In all, we were able to present *U.* *vetiveriae* TZ1 as promising production organism for itaconic acid from glycerol. First metabolic engineering attempts revealed the possibility to improve the product specificity by up-regulation of itaconate production from glycerol.

Conclusions {#Sec8}
===========

Valorization of glycerol from biodiesel production has been a research focus for many years. The identified and improved *U.* *vetiveriae* strain TZ1 contributes a novel strategy, since it is able to produce high titers of organic acids from glycerol. Concentrations above 25 g L^−1^ itaconate seem to be inhibiting, consequently lowering the reached titers in NaOH-titrated bioreactors compared to CaCO~3~-buffered shake flasks, in which the product precipitates as calcium salt. The use of CaCO~3~ as buffering agent in bioreactors might help to overcome this limitation. Additionally, single-gene metabolic engineering allowed a reduction in the main by-product malate, thereby significantly increasing product specificity. Multi gene target metabolic engineering in the evolved *U. vetiveriae* TZ1 harbors huge potential to further improve strain performance. The here described workflow from primary screening, ALE, and medium optimization all the way to first metabolic engineering allows a rapid evaluation of novel host strains for the production of valuable products from alternative carbon sources.

Methods {#Sec9}
=======

Strains and culture conditions {#Sec10}
------------------------------

The 76 strains belonging to the family Ustilaginaceae screened by Zambanini et al. \[[@CR40]\] plus 50 additional strains were screened in this study (Table [3](#Tab3){ref-type="table"}).Table 3Screened strains from the family Ustilaginaceae with final glycerol concentrationNameOriginGly (g L^−1^)Ita (g L^−1^)Mal (g L^−1^)Suc (g L^−1^)*Cintractia axicola* BRIP 26922aQueensland Plant Pathology Herbarium, Australia55*S. modestum* BRIP 26928aQueensland Plant Pathology Herbarium, Australia51*C. lipocarphae* BRIP 26925aQueensland Plant Pathology Herbarium, Australia51*U. porosa* BRIP 26920aQueensland Plant Pathology Herbarium, Australia45*U. maydis* RK 212\[[@CR70]\]42*U. lituana* BRIP 46795aQueensland Plant Pathology Herbarium, Australia42*U. avenae*Centraalbureau Voor Schimmelcultures 13146641*U. maydis* Nr. 484American Type Culture Collection 2290340*S. caledonicum* BRIP 28043aQueensland Plant Pathology Herbarium, Australia40*U. maydis* DSM 14603Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)40*U. maydis* Nr. 213Prof. M. Bölker, Philipps University Marburg, Germany39*U. maydis* DSM 3121Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)37*U. maydis* Nr. 477 a1bPAmerican Type Culture Collection 2289534*U. maydis* Nr. 488American Type Culture Collection 2290734*U. cynodontis* NBRC 7530NITE Biological Resource Center34*U. maydis* Nr. 466 a1bEAmerican Type Culture Collection 2288533*U. maydis* Nr. 483American Type Culture Collection 2290233*U. maydis* Nr. 197Prof. M. Bölker, Philipps University Marburg, Germany32*U. rabenhorstiana* NBRC 8995NITE Biological Resource Center31*U. maydis* Nr. 465 a1bDAmerican Type Culture Collection 2288430*U. maydis* Nr. 206Prof. M. Bölker, Philipps University Marburg, Germany30*U. maydis* Nr. 467 a1bFAmerican Type Culture Collection 2288630*U. maydis* Nr. 482American Type Culture Collection 2290129*U. cynodontis* NBRC 9727NITE Biological Resource Center29*U. maydis* Nr. 204Prof. M. Bölker, Philipps University Marburg, Germany29*U. maydis* Nr. 462 a1bAProf. M. Bölker, Philipps University Marburg, Germany29*U. filiformis* UMa701Centraalbureau Voor Schimmelcultures 13146929*U. maydis* FB1 a1b1Banuett & Herskowitz, 1989, Minnesota USA28*U. maydis* RK 134\[[@CR70]\]28*U. maydis* Nr. 485American Type Culture Collection 2290428*S. tumiforme* BRIP 26919aQueensland Plant Pathology Herbarium, Australia280.90.00.0*U. maydis* RK 215\[[@CR70]\]27*U. maydis* Nr. 489American Type Culture Collection 2290826*U. maydis* Nr. 470 a1bIProf. M. Bölker, Philipps University Marburg, Germany25*U. maydis* RK 123\[[@CR70]\]25*U. maydis* Nr. 198Prof. M. Bölker, Philipps University Marburg, Germany25*U. maydis* Nr. 207Prof. M. Bölker, Philipps University Marburg, Germany24*S. cruentum* UMa920 MAT1Centraalbureau Voor Schimmelcultures 13324924*U. cynodontis* NBRC 9758NITE Biological Resource Center23*U. maydis* RK 122\[[@CR70]\]23*U. maydis* Nr. 490American Type Culture Collection 2290923*U. hordei* Uh4875-4 Mat1\[[@CR71]\]23*U. maydis* Nr. 200Prof. M. Bölker, Philipps University Marburg, Germany22*U. maydis* Nr. 208Prof. M. Bölker, Philipps University Marburg, Germany22*U. maydis* Nr. 487American Type Culture Collection 2290621*U. maydis* Nr. 195Prof. M. Bölker, Philipps University Marburg, Germany21*U. maydis* MB215Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) DSM 1714420*U. maydis* Nr. 209Prof. M. Bölker, Philipps University Marburg, Germany20*U. maydis* RK 213\[[@CR70]\]20*S. consanguineum*Centraalbureau Voor Schimmelcultures 13145619*U. maydis* Nr. 478 a1bQAmerican Type Culture Collection 2289619*U. maydis* RK 214\[[@CR70]\]19*U. maydis* Nr. 212Prof. M. Bölker, Philipps University Marburg, Germany19*U. maydis* Nr. 215Prof. M. Bölker, Philipps University Marburg, Germany19*U. maydis* Nr. 214Prof. M. Bölker, Philipps University Marburg, Germany18*U. maydis* Nr. 205Prof. M. Bölker, Philipps University Marburg, Germany18*U. maydis* Nr. 463 a1bBAmerican Type Culture Collection 2288218*U. maydis* Nr. 481American Type Culture Collection 2290018*U. maydis* Nr. 196Prof. M. Bölker, Philipps University Marburg, Germany17*U. maydis* Nr. 199Prof. M. Bölker, Philipps University Marburg, Germany17*U. maydis* Nr. 492American Type Culture Collection 2291117*U. maydis* Nr. 201Prof. M. Bölker, Philipps University Marburg, Germany17*U. maydis* RK 139\[[@CR70]\]16*C. lipocarphae* BRIP 26927aQueensland Plant Pathology Herbarium, Australia15*U. maydis* Nr. 469 a1bHAmerican Type Culture Collection 1860414*U. maydis* Nr. 479 a1bRAmerican Type Culture Collection 2289714*U. maydis* Nr. 211Prof. M. Bölker, Philipps University Marburg, Germany14*S. exsertum* RK 033Centraalbureau Voor Schimmelcultures 13145714*U. schmidtiae* BRIP 26906aQueensland Plant Pathology Herbarium, Australia13*U. maydis* Nr. 491American Type Culture Collection 2291013*Ustanciosporium gigantosporum* UMa706Centraalbureau Voor Schimmelcultures 13147812*Cintractia sp*. BRIP 60413aQueensland Plant Pathology Herbarium, Australia12*U. maydis* Nr. 480American Type Culture Collection 2289912*U. maydis* Nr. 495American Type Culture Collection 22191412*U. maydis* DSM 4500Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)11*U. maydis* HB1990Biotechnology And Information Research Network AG, Zwingenberg, Germany11*U. maydis* Nr. 476 a1bOAmerican Type Culture Collection 2289411*S. setariae* BRIP 26910aQueensland Plant Pathology Herbarium, Australia10*C. sp*. BRIP 60422aQueensland Plant Pathology Herbarium, Australia10*U. maydis* Nr. 202Prof. M. Bölker, Philipps University Marburg, Germany8*M. spermophorus* BRIP 60430aQueensland Plant Pathology Herbarium, Australia7*M. spermophorus* BRIP 60448aQueensland Plant Pathology Herbarium, Australia7*S. scitamineum* UMa698, Sscl4, JS109, MAT1Centraalbureau Voor Schimmelcultures 1314627*S. ovarium* BRIP 26909aQueensland Plant Pathology Herbarium, Australia6*S. themedae* BRIP 26917aQueensland Plant Pathology Herbarium, Australia6*S. aristidicola* BRIP 26930aQueensland Plant Pathology Herbarium, Australia6*U. maydis* Nr. 471 a1bJAmerican Type Culture Collection 228895*U. cynodontis* BRIP 28040aQueensland Plant Pathology Herbarium, Australia5*U. maydis* Nr. 203Prof. M. Bölker, Philipps University Marburg, Germany4*S. walkeri* RK 031Centraalbureau Voor Schimmelcultures 1314644*A. heteropogonicola* BRIP 60896aQueensland Plant Pathology Herbarium, Australia3*C. mitchellii* BRIP 26923aQueensland Plant Pathology Herbarium, Australia2*U. maydis* FB2 a2b2Banuett & Herskowitz, 1989, Minnesota USA2*Anthracocystis sehimatis* BRIP 60890aQueensland Plant Pathology Herbarium, Australia20.00.00.0*U. maydis* Nr. 474 a1bMAmerican Type Culture Collection 228922*P. antarctica* NBRC 10260NITE Biological Resource Center1*A. bothriochloae* BRIP 60901aQueensland Plant Pathology Herbarium, Australia10.00.00.0*U. cynodontis* UMa709Centraalbureau Voor Schimmelcultures 1314671*S. iseilematis*-*ciliati* BRIP 60429aQueensland Plant Pathology Herbarium, Australia0*M. ordensis* BRIP 26904aQueensland Plant Pathology Herbarium, Australia01.00.00.0*U. curta* BRIP 26929aQueensland Plant Pathology Herbarium, Australia0*S. lanigeri* BRIP 27609aQueensland Plant Pathology Herbarium, Australia01.00.00.0*U. maydis* Nr. 473 a1bLAmerican Type Culture Collection 228910*M. eriachnes* RK 028Centraalbureau Voor Schimmelcultures 1314540*U. trichophora* RK089Centraalbureau Voor Schimmelcultures 1314730*U. vetiveriae* RK 075Centraalbureau Voor Schimmelcultures 13147400.60.70.2*U. xerochloae* UMa702Centraalbureau Voor Schimmelcultures 13147600.21.70.0*P. hubeiensis* NBRC 105053NITE Biological Resource Center01.00.00.0*P. hubeiensis* NBRC 105054NITE Biological Resource Center00.70.00.0*P. hubeiensis* NBRC 105055NITE Biological Resource Center00.70.00.0*U. trichophora* NBRC 100155NITE Biological Resource Center02.20.00.7*U. trichophora* NBRC 100156NITE Biological Resource Center01.80.00.7*U. trichophora* NBRC 100157NITE Biological Resource Center01.50.00.5*U. trichophora* NBRC 100158NITE Biological Resource Center00.00.00.0*U. trichophora* NBRC 100159NITE Biological Resource Center01.40.00.4*U. trichophora* NBRC 100160NITE Biological Resource Center02.10.00.3*P. tsukubaensis* NBRC 1940NITE Biological Resource Center00.80.10.0*M. mackinlayi* BRIP 52549aQueensland Plant Pathology Herbarium, Australia01.10.00.0*S. cenchri*-*elymoidis* BRIP 26491aQueensland Plant Pathology Herbarium, Australia01.70.00.0*S. bothriochloae* BRIP 26908aQueensland Plant Pathology Herbarium, Australia0*U. triodiae* BRIP 26907aQueensland Plant Pathology Herbarium, Australia0*M. tubiformis* BRIP 60434aQueensland Plant Pathology Herbarium, Australia00.00.00.0*U. xerochloae* BRIP 60876aQueensland Plant Pathology Herbarium, Australia02.70.00.2*S. iseilematis*-*ciliati* BRIP 60887aQueensland Plant Pathology Herbarium, Australia00.02.50.0*A. caledonica* BRIP 60892aQueensland Plant Pathology Herbarium, Australia00.00.00.0*U. egenula* BRIP 60884 aQueensland Plant Pathology Herbarium, Australia00.00.00.0

As standard medium, MTM was used according to Zambanini et al. containing 100 g L^−1^ CaCO~3~ with differing concentrations of FeSO~4~, MgSO~4~, and KH~2~PO~4~ and differing concentrations of NH~4~Cl, yeast extract, or peptone (see text for details) \[[@CR40]\].

Adaptive laboratory evolution (for 62 days), medium optimization, preparation of pre-cultures, shake flask experiments, and batch cultivations were conducted as described previously \[[@CR40], [@CR41]\]. For batch cultivations, the pH was set to 6.5 and controlled by automatic addition of 10 M NaOH.

Analytical methods {#Sec11}
------------------

All experiments were performed in duplicates. Shown is the arithmetic mean of the duplicates. Error bars and ± values indicate deviation from the mean.

Samples were treated as described previously \[[@CR40], [@CR41]\]. OD~600~ determination and HPLC analysis were performed as described previously \[[@CR40]\]. Ammonium concentration was determined by a colorimetric assay according to Willis \[[@CR69]\].

The nitrogen content of peptone and yeast extract was determined by Mikroanalytisches Laboratorium Kolbe~(Nachf.)~ (Mülheim an der Ruhr, Germany).

Cloning procedures {#Sec12}
------------------

For overexpression of *ria1* and *mtt1*, the overexpression constructs generated by Geiser et al. were used \[[@CR27]\].

All cloning procedures were performed as described previously \[[@CR52]\].
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